WAM
Weatherly Asset Management Portfolio holdings
AUM
$1.17B
This Quarter Return
-0.18%
1 Year Return
+11.93%
3 Year Return
+96.26%
5 Year Return
+156.28%
10 Year Return
+475.09%
AUM
$1.13B
AUM Growth
+$1.13B
(-1.2%)
Cap. Flow
+$16.9M
Cap. Flow
% of AUM
1.5%
Top 10 Holdings %
Top 10 Hldgs %
51.78%
Holding
190
New
11
Increased
56
Reduced
80
Closed
9
Top Buys
| 1 |
Fidelity Total Bond ETF
FBND
|
$3.41M |
| 2 |
SPDR DoubleLine Total Return Tactical ETF
TOTL
|
$1.38M |
| 3 |
JPMorgan Ultra-Short Income ETF
JPST
|
$1.3M |
| 4 |
Broadcom
AVGO
|
$1.2M |
| 5 |
Fidelity MSCI Health Care Index ETF
FHLC
|
$1.18M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$3.25M |
| 2 |
Invesco S&P Global Water Index ETF
CGW
|
$1.87M |
| 3 |
Apple
AAPL
|
$1.76M |
| 4 |
Netflix
NFLX
|
$811K |
| 5 |
NVIDIA
NVDA
|
$780K |
Sector Composition
| 1 | Technology | 22.73% |
| 2 | Healthcare | 22.51% |
| 3 | Consumer Discretionary | 7.79% |
| 4 | Communication Services | 7.7% |
| 5 | Industrials | 6.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
iShares Silver Trust
SLV
$20.2B
| $205K | 0.02% |
7,795
| – | – |
|
177
Schwab Short-Term US Treasury ETF
SCHO
$11.7B
| $205K | 0.02% |
8,500
+4,250
| +100% | – |
|
178
Conagra Brands
CAG
$9.19B
| $204K | 0.02% |
7,353
-132
| -2% | -$3.66K |
|
179
Linde
LIN
$221B
| $202K | 0.02% |
483
-56
| -10% | -$23.4K |
|
180
Medtronic
MDT
$118B
| $201K | 0.02% |
2,494
-59
| -2% | -$4.75K |
|
181
Mondelez International
MDLZ
$79.3B
| $201K | 0.02% |
3,333
+85
| +3% | +$5.12K |
|
182
Vanguard Health Care ETF
VHT
$15.5B
| – | – |
-784
| Closed | -$222K |
|
183
Timken Company
TKR
$5.23B
| – | – |
-4,890
| Closed | -$412K |
|
184
Regal Rexnord
RRX
$9.44B
| – | – |
-1,083
| Closed | -$324K |
|
185
Novo Nordisk
NVO
$252B
| – | – |
-2,282
| Closed | -$272K |
|
186
Marathon Petroleum
MPC
$54.4B
| – | – |
-1,335
| Closed | -$217K |
|
187
Equifax
EFX
$29.3B
| – | – |
-796
| Closed | -$234K |
|
188
Chubb
CB
$111B
| – | – |
-809
| Closed | -$234K |
|
189
Bristol-Myers Squibb
BMY
$96.7B
| – | – |
-5,084
| Closed | -$263K |
|
190
Advanced Micro Devices
AMD
$263B
| – | – |
-1,295
| Closed | -$212K |
|